PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.00%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-57.72%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-544.67%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-544.67%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
487.94%
Positive net income growth while LBL.AX is negative. John Neff might see a big relative performance advantage.
234.62%
Positive EPS growth while LBL.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
280.00%
Positive diluted EPS growth while LBL.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
74.90%
Share count expansion well above LBL.AX's 2.48%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
58.90%
Diluted share count expanding well above LBL.AX's 2.48%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3736.36%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
31.79%
10Y revenue/share CAGR under 50% of LBL.AX's 228.01%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
10Y OCF/share CAGR above 1.5x LBL.AX's 45.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
216.80%
Net income/share CAGR 1.25-1.5x LBL.AX's 196.67%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
No Data
No Data available this quarter, please select a different quarter.
137.30%
Positive short-term CAGR while LBL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-77.11%
We cut SG&A while LBL.AX invests at 28.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.